Our mission is to advance infectious disease diagnosis and improve patient care using novel diagnostic platforms that produces rapid and accurate results from patient samples. Our versatile platforms address critical needs for current infectious disease epidemics such as tuberculosis, HIV, and non-tuberculosis mycobacteria (NTM).
NanoPin is currently offering diagnostic services for active Tuberculosis in our CLIA facility. Our NanoDetect-TB assay is direct-in-blood and enables early and accurate detection of active TB in any body - infant, young children, or adult, previously BCG vaccinated, and HIV co-infected. The assay is uniquely capable in extrapulmonary TB.
Company Details
- Employees
- 2
- Founded
- 2017
- Address
- New Orleans, La 70112, Us
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- http://www.nanopintech.com
- HQ
- New Orleans, LA
Nanopin Technologies, Inc. Questions
Nanopin Technologies, Inc.'s website is http://www.nanopintech.com
Nanopin Technologies, Inc.'s LinkedIn profile is https://www.linkedin.com/company/nanopin-technologies-inc
Nanopin Technologies, Inc. has
2 employees.
View email and phone details for 2
employees at Nanopin Technologies, Inc..
Nanopin Technologies, Inc.'s industry is
Medical and Diagnostic Laboratories
Nanopin Technologies, Inc.'s top competitors are
Nanospin,
Pdc Pharma Strategy,
Nanotherics, Ltd,
Cytimmune Sciences,
Nanovalent Pharmaceuticals, Inc.,
Sgn Nanopharma Inc,
Nanomerics Ltd,
Therapyx Inc,
Matexcel,
Nanosphere.
Nanopin Technologies, Inc.'s categories are Medical and Diagnostic Laboratories
Nanopin Technologies, Inc.'s founding year is 2017
